Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Phunware, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2018
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
26.7
30.9
19.2
10
10.6
6.52
4.83
3.19
2.55
Cost of revenue
15.7
11.8
9.02
3.36
7.03
3.01
3.15
1.74
1.26
Gross profit
11
19.1
10.1
6.64
3.61
3.51
1.69
1.45
1.29
Research and development
11.1
6.97
4.33
2.63
4.18
6.15
4.45
2.27
3.16
Selling and marketing
10.7
5.42
2.71
1.65
3.02
4.11
3.33
2.61
3.35
General and administrative
14.8
13.6
15.4
15.4
13.3
17.3
13.8
10.5
15.3
Operating expenses
36.6
25.9
22.4
24.1
20.5
27.5
47.4
15.3
21.8
Operating income
-25.6
-1.68
-6.86
-12.3
-17.5
-16.8
-24
-45.7
-13.9
-20.5
Interest expense
0.4
0.72
0.58
3.41
4.48
2.41
1.73
0.14
0.03
Interest income
1.73
4.27
Other non-operating income
-0.41
-3.31
-0.55
-4.7
-37.1
-21.4
3.78
3.61
9.1
Pre-tax income
-26
-10.2
-12.9
-22.2
-53.9
-45.4
-41.9
-10.3
-11.4
Income tax
-0.09
-0.37
0.01
0
-0.43
0
0.03
0.04
-0.02
Income from continuing operations
-45.4
-41.9
-10.3
Net income
-25.9
-0.92
-9.8
-12.9
-22.2
-53.5
-50.9
-52.8
-10.3
-11.4
EBITDA
-25.5
-6.8
-12.3
-17.5
EPS, basic
-1.06
-0.33
-0.38
-0.35
-0.50
-0.71
-0.51
-0.94
-0.57
EPS, diluted
-1.06
-0.33
-0.38
-0.35
-0.50
-0.71
-0.51
-0.94
-0.57
Shares, basic (weighted)
24.5
2.83
25.6
36.9
44.3
75.4
1.98
2.38
11
20.2
Shares, diluted (weighted)
24.5
2.83
25.6
36.9
44.3
75.4
1.98
2.38
11
20.2
Dividend per share
0.00
0.00
Balance sheet
FY2018
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0.31
0
0.84
0.28
3.94
23.1
1.96
3.93
113
101
Receivables
6.21
3.61
1.67
0.66
0.97
0.84
0.55
0.28
0.3
Inventory
0
2.64
2.78
Other current assets
0.39
0.02
0.27
0.37
0.3
0.69
0.61
0.37
0.41
19.2
Total current assets
6.9
0.02
4.72
2.32
4.91
60
16.9
4.96
114
120
Property, plant and equipment
0.13
0.07
0.02
0.01
0
0.19
0.04
0.02
0.01
Lease right-of-use assets
0
1.26
2.3
1.45
0.84
0.55
Goodwill
25.9
25.9
25.9
25.9
33.3
25.8
0
Intangible assets
0.9
0.52
0.25
0.11
3.21
2.52
Other non-current assets
0.16
Total assets
34
19.7
36.9
29.1
31.8
98
54.8
6.73
115
121
Accounts payable
3.55
0.78
9.89
10.2
8.46
6.59
7.28
7.84
3.75
1.07
Accrued liabilities
8.8
3.03
4.04
5.35
9.62
2.74
0.44
0.15
19.9
Deferred revenue
1.04
2.63
3.36
2.4
3.97
2.9
1.26
1.03
1.39
Short-term debt
0
4.44
4.9
9.67
4.94
Total current liabilities
15.2
2.6
20
19.8
26.5
30.3
25.6
16.5
6.45
23.9
Long-term debt
0
0.91
3.76
0
Lease liabilities
0
1.15
1.93
1.03
0.62
0.28
Other non-current liabilities
3.24
Total liabilities
26.1
3.06
25.7
25
33.8
32.7
30
18.2
7.6
24.6
Total debt
0
1.11
10.1
5.22
9.67
4.94
Paid-in capital
110
6.32
118
128
144
265
276
292
421
422
Retained earnings
-102
-1.32
-112
-124
-146
-199
-250
-303
-313
-325
Treasury stock
0
-0.5
-0.5
-0.5
Other comprehensive income
-0.35
-0.42
-0.38
-0.34
-0.35
-0.47
-0.42
Shareholders' equity
7.9
5
5.83
4.03
-1.98
65.3
24.9
-11.5
107
96.3
Total equity
7.9
5
5.83
4.03
-1.98
65.3
24.9
-11.5
107
96.3
Total liabilities and equity
34
19.7
36.9
29.1
31.8
98
54.8
6.73
115
121
Shares outstanding
24,560
2.87
27.3
39.8
56.4
96.8
2.06
3.85
20.2
20.2
Cash flow statement
FY2018
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-25.9
-0.92
-9.8
-12.9
-22.2
-53.5
-50.9
-52.8
-10.3
-11.4
Depreciation and amortization
0.15
0.06
0.06
0.01
Stock-based compensation
0.12
0.45
1.78
4.49
4.94
3.01
4.07
1.66
0.46
Deferred income tax
-0.09
-0.39
0
0
-0.44
0
0
0
0
Change in receivables
-1.24
2.44
1.82
0.8
-0.02
0
0.24
0.13
-0.02
Change in inventory
0
-0.95
-0.41
Change in payables
-0.9
0.65
4.16
0.74
0.43
-1.57
0.73
0.56
-2.93
-0.27
Cash from operations
-17
-1.04
-6.59
-6.19
-11
-22.5
-26.9
-18.4
-13.3
-12.5
Capital expenditures
0
-0.02
0
0
-0.92
0
Acquisitions
0
-5.1
-2.38
Sales and maturities of investments
3.24
5.45
Cash from investing
-0.03
52.3
0.38
0.07
0
-46.4
-2.26
15.4
0
0
Debt repaid
-5.06
Stock issued
0.41
5.45
0
9.18
94.7
4.3
10.5
122
0.08
Share buybacks
-52.6
0
-0.5
Cash from financing
4.62
-51.3
12.3
0.1
14.6
88
8.06
4.98
122
0.08
Exchange rate effect
0.08
-0.07
0.04
0.05
-0.01
-0.12
0.06
Net change in cash
-12.3
-0.12
6.04
-5.98
3.67
19.1
-21.2
1.98
109
-12.4
Free cash flow
-6.59
-6.21
-11
-22.5
-27.8
-18.4
Interest paid
0.38
0.71
0.6
1.25
1.36
0.96
1.22
0.03
0.03
Income taxes paid
0
0
0
0
0.01
0.03
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.97 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
61.0%
Gross profit / revenue.
Operating margin
-782.1%
Operating income / revenue.
Pre-tax margin
-472.4%
Pre-tax income / revenue.
Net margin
-471.7%
Net income / revenue.
Operating cash flow margin
-513.7%
Cash from operations / revenue.
Return on equity (ROE)
-14.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-13.9%
Net income / average total assets.
R&D / revenue
134.9%
Research and development expense / revenue.
Stock-based pay / revenue
32.2%
Stock-based compensation (from the cash flow statement) / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-19.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-26.8%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-23.9%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-11.2%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-28.3%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-27.9%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-10.1%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
57.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
5.3%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
30.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
30.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
83.9%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
116.8%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-14.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
19.8x
Current assets / current liabilities.
Quick ratio
19.7x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
19.7x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.13
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.69
Cash from operations / diluted weighted shares.
Book value per share
$4.33
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
14.7x
Market cap / revenue.
P/B
0.46x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.46x
Market cap / tangible book value, when positive.
Earnings yield
-32.2%
Net income / market cap (the inverse of P/E).
What was Phunware, Inc.'s revenue in fiscal 2025?
Phunware, Inc. reported revenue of $2.6M for fiscal 2025, 19.9% lower than the year before.
Was Phunware, Inc. profitable in fiscal 2025?
No. It reported a net loss of $11.4M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.